Precision medicine research at Karmanos comparing biomarker
By A Mystery Man Writer
Description
A Barbara Ann Karmanos Cancer Institute clinical researcher and her team have received $16,000 to further research in precision medicine for breast cancer treatment. Common Citizen leadership delivered the check to Jailan Elayoubi, M.D. , medical oncologist and member of the Breast Cancer and Phase 1 Clinical Trials Multidisciplinary Teams, in November 2023. Dr. Elayoubi and her team have made significant strides in studying biomarkers and tumor molecular characteristics that may predict sensitivity and
The role of biomarkers in personalized immunotherapy
Researchers: Genes could be key in cancer fight
AI in early drug and biomarker discovery. (a) Deep learning
PDF) TMB: a promising immune-response biomarker, and potential
Cancer screening event at Karmanos Cancer Institute to help Southeast Michigan get back on track
Barbara Ann Karmanos Cancer Institute
Halabi et al KCJ19n3 2021
Karmanos Cancer Institute and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
Cancer Biomarkers: Powering Precision Medicine
IJMS, Free Full-Text
Efficacy of Platinum Rechallenge in Metastatic Urothelial
from
per adult (price varies by group size)